Clinical characteristics of patients with Perry syndrome with DCTN1 mutations
| Patients (n) | 87 |
| Age at onset (n) | 61 |
| Mean±SD (years) | 49.1±6.6 |
| Range (years) | 35–70 |
| Age at death (n) | 54 |
| Mean±SD (years) | 55.0±7.4 |
| Range (years) | 39–81 |
| Disease duration (n) | 37 |
| Mean±SD (years) | 5.5±2.5 |
| Range (years) | 2–14 |
| Four cardinal signs (n) | 63 |
| Parkinsonism (%) | 95.2 (60/63) |
| Tremor (%) | 51.7 (31/60) |
| Rigidity (%) | 60.0 (36/60) |
| Bradykinesia (%) | 38.3 (23/60) |
| Postural instability (%) | 23.3 (14/60) |
| Response to dopaminergic treatments (%) | 86.5 (32/37) |
| Depression/apathy (%) | 71.4 (45/63) |
| Respiratory symptoms (%) | 66.7 (42/63) |
| Weight loss (%) | 49.2 (31/63) |
| Other features (n) | 63 |
| Frontal signs (%) | 19.0 (12/63) |
| Oculomotor disorders (%) | 15.9 (10/63) |
| Cognitive impairment (%) | 15.9 (10/63) |
| Dysphasia (%) | 14.3 (9/63) |
| Sleep disturbances (%) | 20.6 (13/63) |
| Autonomic dysfunction (%) | 9.5 (6/63) |
| Initial symptoms (n) | 66 |
| Depression/apathy (%) | 56.1 (37/66) |
| Parkinsonism (%) | 54.5 (36/66) |
| Weight loss (%) | 9.1 (6/66) |
| Respiratory failure (%) | 3.0 (2/66) |
| Cause of death (n) | 33 |
| Respiratory failure/pneumonia (%) | 60.6 (20/33) |
| Sudden death (%) | 15.2 (5/33) |
| Others (%) | 24.2 (8/33) |